Your browser doesn't support javascript.
loading
Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma.
Fujishita, T; Kojima, Y; Kajino-Sakamoto, R; Taketo, M M; Aoki, M.
  • Fujishita T; Division of Molecular Pathology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
  • Kojima Y; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoé-cho, Sakyo-ku, Kyoto, Japan.
  • Kajino-Sakamoto R; Division of Molecular Pathology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
  • Taketo MM; Division of Molecular Pathology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
  • Aoki M; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoé-cho, Sakyo-ku, Kyoto, Japan.
Oncogene ; 36(46): 6480-6489, 2017 11 16.
Article en En | MEDLINE | ID: mdl-28759045

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Resistencia a Antineoplásicos / Serina-Treonina Quinasas TOR / Microambiente Tumoral / Neoplasias Intestinales / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Resistencia a Antineoplásicos / Serina-Treonina Quinasas TOR / Microambiente Tumoral / Neoplasias Intestinales / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article